Chiao-ling Li

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 18, 2026

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC.

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC.

Journal: Journal of biomedical science

Published: June 06, 2024

Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.

Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.

Journal: International journal of cancer

Published: June 17, 2023

HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features.

HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features.

Journal: Liver cancer

Published: November 14, 2022

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC.

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC.

Journal: Cellular and molecular gastroenterology and hepatology

Published: November 03, 2022

Circulating Virus-Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers.

Circulating Virus-Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers.

Journal: Cancers

Published: March 18, 2022

D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.

D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.

Journal: mBio

Published: July 27, 2021

Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.

Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.

Journal: Cell reports

Published: May 21, 2020

Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.

Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.

Journal: Hepatology (Baltimore, Md.)

Published: October 15, 2019

Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.

Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.

Journal: Hepatology (Baltimore, Md.)

Published: February 23, 2018

Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.

Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.

Journal: International journal of cancer

Published: December 10, 2013

ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers.

ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers.

Journal: PloS one

Published: July 31, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026